These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14659432)

  • 1. Liquid chromatographic assays for DE-310, a novel camptothecin analog, and two major enzymatic products in human matrices.
    Soepenberg O; de Bruijn P; Verweij J; Atsumi R; Sparreboom A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jan; 799(1):15-22. PubMed ID: 14659432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation study of assay method for DE-310, a novel polymer-bound camptothecin derivative, and the free drug in mouse plasma by liquid chromatography with fluorimetric detection.
    Oguma T; Konno T; Nakaoka M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Mar; 801(2):157-64. PubMed ID: 14751783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatographic determination of irinotecan and three major metabolites in human plasma, urine and feces.
    Sparreboom A; de Bruijn P; de Jonge MJ; Loos WJ; Stoter G; Verweij J; Nooter K
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 712(1-2):225-35. PubMed ID: 9698245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Femtomole quantitation of 7-ethyl-10-hydroxycamptothecine (SN-38) in plasma samples by reversed-phase high-performance liquid chromatography.
    de Bruijn P; de Jonge MJ; Verweij J; Loos WJ; Nooter K; Stoter G; Sparreboom A
    Anal Biochem; 1999 Apr; 269(1):174-8. PubMed ID: 10094790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of irinotecan (CPT-11) and SN-38 in human whole blood and red blood cells by liquid chromatography with fluorescence detection.
    de Jong FA; Mathijssen RH; de Bruijn P; Loos WJ; Verweij J; Sparreboom A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 795(2):383-8. PubMed ID: 14522044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation study of a method for assaying DE-310, a macromolecular carrier conjugate containing an anti-tumor camptothecin derivative, and the free drug in human plasma by HPLC and LC/MS/MS.
    Oguma T; Cicci D; Gaudette F; Gauthier-Dubois G; Guilbaud R; Atsumi R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):249-56. PubMed ID: 15734166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation study of a method for assaying DE-310, a macromolecular carrier conjugate containing an anti-tumor camptothecin derivative, and the free drug in tumor tissue by high performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry.
    Oguma T; Morikawa H; Iwasaki D; Atsumi R
    Biomed Chromatogr; 2005 Jan; 19(1):19-26. PubMed ID: 15484225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Performance liquid chromatographic analysis of lactone and hydroxy acid of new antitumor drug, DX-8951 (exatecan), in mouse plasma.
    Oguma T; Yamada M; Konno T; Inukai K; Nakaoka M
    Biol Pharm Bull; 2001 Feb; 24(2):176-80. PubMed ID: 11217088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive HPLC-fluorescence method for irinotecan and four major metabolites in human plasma and saliva: application to pharmacokinetic studies.
    Poujol S; Pinguet F; Malosse F; Astre C; Ychou M; Culine S; Bressolle F
    Clin Chem; 2003 Nov; 49(11):1900-8. PubMed ID: 14578322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation study of assay method for DX-8951 and its metabolite in human plasma and urine by high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry.
    Oguma T; Konno T; Inaba A; Nakaoka M
    Biomed Chromatogr; 2001 Apr; 15(2):108-15. PubMed ID: 11268051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of topotecan in human whole blood and unwashed erythrocytes by high-performance liquid chromatography.
    Loos WJ; van Zomeren DM; Gelderblom H; Verweij J; Nooter K; Stoter G; Sparreboom A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(1):99-105. PubMed ID: 11820300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid chromatography determination of 10-hydroxycamptothecin in human serum by a column-switching system containing a pre-column with restricted access media and its application to a clinical pharmacokinetic study.
    Ma J; Jia ZP; Zhang Q; Fan JJ; Jiang NX; Wang R; Xie H; Wang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 796(1):195-200. PubMed ID: 14552831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative determination of DRF-1042 in human plasma by HPLC: validation and application in clinical pharmacokinetics.
    Upreti VV; Mamidi RN; Katneni K; Srinivas NR
    Biomed Chromatogr; 2003 Sep; 17(6):385-90. PubMed ID: 13680849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a simple reversed-phase HPLC method for the determination of camptothecin in animal organs following administration in solid lipid nanoparticles.
    Martins SM; Wendling T; Gonçalves VM; Sarmento B; Ferreira DC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 880(1):100-7. PubMed ID: 22153332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a high-performance liquid chromatographic method to determine the concentration of karenitecin, a novel highly lipophilic camptothecin derivative, in human plasma and urine.
    Smith JA; Hausheer F; Newman RA; Madden TL
    J Chromatogr B Biomed Sci Appl; 2001 Aug; 759(1):117-24. PubMed ID: 11499615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection.
    de Bruijn P; Verweij J; Loos WJ; Nooter K; Stoter G; Sparreboom A
    J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):277-85. PubMed ID: 9367218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal lurtotecan (NX211): determination of total drug levels in human plasma and urine by reversed-phase high-performance liquid chromatography.
    Loos WJ; Kehrer D; Brouwer E; Verweij J; de Bruijn P; Hamilton M; Gill S; Nooter K; Stoter G; Sparreboom A
    J Chromatogr B Biomed Sci Appl; 2000 Jan; 738(1):155-63. PubMed ID: 10778937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an HPLC method to quantify camptothecin in polymeric nanocapsule suspensions.
    Granada A; Murakami FS; Sartori T; Lemos-Senna E; Silva MA
    J AOAC Int; 2008; 91(3):551-6. PubMed ID: 18567300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: application to pharmacokinetic studies.
    Bansal T; Awasthi A; Jaggi M; Khar RK; Talegaonkar S
    Talanta; 2008 Sep; 76(5):1015-21. PubMed ID: 18761148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of polyamines in human saliva by high-performance liquid chromatography with fluorescence detection.
    Venza M; Visalli M; Cicciu D; Teti D
    J Chromatogr B Biomed Sci Appl; 2001 Jun; 757(1):111-7. PubMed ID: 11419735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.